Companies › TWST

TWIST BIOSCIENCE CORP (TWST)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001581280 · EDGAR filings · Updated 2026-07-27

TWIST BIOSCIENCE CORP (TWST) has reported institutional ownership of 123.7%, with 280 institutional managers holding positions valued at $3.66B per the latest 13F reporting period.

Filings this week (2)

• 2026-07-27 — Insider transaction reported (Form 4)
• 2026-07-23 — Notice of proposed sale filed (Form 144)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-13 — Insider transaction reported (Form 4)
• 2026-07-09 — Notice of proposed sale filed (Form 144)
• 2026-06-26 — Insider transaction reported (Form 4)
• 2026-06-26 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, TWIST BIOSCIENCE CORP has 280 institutional holders and institutional ownership of 123.7%.

Insider activity

Insiders reported 158 transactions (0 buys, 128 sells) across 13 reporting insiders, with a net reported value of −$18.8M.

Related companies

EDGEWISE THERAPEUTICS INC (EWTX) · CRISPR THERAPEUTICS AG (CRSP) · ACADIA PHARMACEUTICALS INC COM (ACAD) · TRANSMEDICS GROUP INC (TMDX) · TG THERAPEUTICS INC (TGTX) · INTEGER HLDGS CORP (ITGR)